1 Pain score |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
1.1 Clobetasol vs placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
2 Pain resolution |
2 |
72 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.91 [1.08, 3.36] |
2.1 Flucinonide vs placebo |
1 |
40 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.17 [1.03, 4.55] |
2.2 Clobetasol vs placebo |
1 |
32 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.6 [0.67, 3.84] |
3 Clinical score |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
Totals not selected |
3.1 Clobetasol vs placebo |
1 |
|
Mean Difference (IV, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
4 Clinical resolution |
2 |
72 |
Risk Ratio (M‐H, Fixed, 95% CI) |
6.0 [0.76, 47.58] |
4.1 Flucinonide vs placebo |
1 |
40 |
Risk Ratio (M‐H, Fixed, 95% CI) |
9.0 [0.52, 156.91] |
4.2 Clobetasol vs placebo |
1 |
32 |
Risk Ratio (M‐H, Fixed, 95% CI) |
3.0 [0.13, 68.57] |
5 Adverse effects |
3 |
88 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.48 [0.48, 4.56] |
5.1 Flucinonide vs placebo |
1 |
40 |
Risk Ratio (M‐H, Fixed, 95% CI) |
0.0 [0.0, 0.0] |
5.2 Triamcinolone vs placebo |
1 |
16 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.29 [0.37, 4.53] |
5.3 Clobetasol vs placebo |
1 |
32 |
Risk Ratio (M‐H, Fixed, 95% CI) |
2.0 [0.20, 19.91] |